Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M<sup>pro</sup>) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)-Reference-Cited by-同舟云学术

Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M^pro) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Published:2022-12-23 Issue:1 Volume:6 Page:171-180
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Sahoo Pritiranjan¹,Lenka Dipti Ranjan¹,Batabyal Monojit²^ORCID,Pain Pritam Kumar²,Kumar Sangit²^ORCID,Manna Debasish²,Kumar Atul¹^ORCID

Affiliation:

1. Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal, Madhya Pradesh 462066, India

2. Department of Chemistry, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal, Madhya Pradesh 462066, India

Funder

Science and Engineering Research Board

Department of Biotechnology , Ministry of Science and Technology

Indian Institute of Science Education and Research Bhopal

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.2c00203

Reference33 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. CORONAVIRUSES (CORONAVIRIDAE)

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

4. Chemistry and Biology of SARS-CoV-2

5. Cysteine proteases of positive strand RNA viruses and chymotrypsin-like serine proteases

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions;European Journal of Medicinal Chemistry;2024-11

2. 3-chymotrypsin-like protease in SARS-CoV-2;Bioscience Reports;2024-08

3. Repurposing the Open Global Health Library for the discovery of novel Mpro destabilizers with scope as broad-spectrum antivirals;Frontiers in Pharmacology;2024-07-10

4. Selenization of Small Molecule Drugs: A New Player on the Board;Journal of Medicinal Chemistry;2024-05-08

5. New insights in the mechanism of the SARS-CoV-2 Mpro inhibition by benzisoselenazolones and diselenides;2024-03-28